Pantoprazole Sodium Sesquihydrate CRS (Y0000835)
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

164579-32-2Pantoprazole Sodium Sesquihydrate CRS (Y0000835)

● In Stock

Catalogue No.:PVE00463
CAS No.:164579-32-2
Mol. Formula:C16H14F2N3O4S : Na : 3/2(H2O)
Mol. Weight:382.4 : 23.0 : 3/2(18.0) g/mol

Additional information on CAS 164579-32-2

Parent drug

Pantoprazole

IUPAC Name

5-(Difluoromethoxy)-2-(((3, 4-dimethoxypyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide Sodium Sesquihydrate

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

O=[S](C1=NC2=CC(OC(F)F)=CC=C2[N-]1)CC(N=CC=C3OC)=C3OC.[Na+].[3/2H2O]

Description

The compound Piroxicam CRS (P2130000) is a highly characterized reference material that meets stringent regulatory standards | including those set by USP | EMA | JP | and BP. This product is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Piroxicam production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). Additionally | the product comes with a detailed Structure Elucidation Report (SER) | ensuring its precision and reliability for comprehensive analytical use.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url